Top Markets
Coin of the day
Renascience Inc. Renascience Inc.

Renascience Inc.

4889
Rangering i aksjer #21014
Renascience Inc., established in 2000 and based in Tokyo, Japan, is actively... Renascience Inc., established in 2000 and based in Tokyo, Japan, is actively engaged in pioneering and bringing to market pharmaceuticals and medical devices throughout Japan. The company's pipeline includes RS5614, a PAI-1 inhibitor that has reached Phase 3 clinical trials for a wide range of indications such as chronic myeloid leukemia, malignant melanoma, non-small cell lung cancer, novel coronavirus infections, and FGF23-related hypophosphatemic rickets. Another PAI-1 inhibitor, RS5441, is currently in Phase 1 trials for various dermatological conditions. Additionally, RS8001, a water-soluble vitamin, is undergoing Phase 2 clinical development for the treatment of premenstrual syndrome/premenstrual dysphoric mood disorder, autism spectrum disorder, and menopausal disorder. Beyond its pharmaceutical ventures, Renascience is also advancing the RS9001 disposable ultrafine endoscope, alongside developing artificial intelligence-driven medical solutions and comprehensive diagnostic tools.
Aksjekurs
$8.49
Sist synkronisert: 2026-08-21
Markedsverdi
$117.03M
Endring (1 dag)
-4.82%
Endring (1 år)
-45.48%
Land
JP
Handel Renascience Inc. (4889)

Kategori

Aksjeprishistorikk for Renascience Inc. (4889)
Høyeste sluttskurs: $8.43 den 2026-08-01

Laveste sluttskurs: $7.05 den 2021-09-01
Aksjeprishistorikk for Renascience Inc. fra 2021 til 2026
Årlig aksjeprisytelse
År Ytelse
2026 (TTM) 2.00%
2025 471.92%
2024 -36.21%
2023 18.40%
2022 -62.92%
2021 0.00%
Aksjepris for lignende selskaper eller konkurrenter
Selskap Aksjepris Endring 1år% Land
$547.71 38.62%
US
$1.04K 58.06%
NL
$145.75 437.43%
US
$118.70 -15.60%
AU
$770.19 8.98%
CH